Comparison of long‐term safety of fixed‐dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide

This 52‐week, randomized, open‐label study evaluated long‐term safety/tolerability of fixed‐dose combination azilsartan medoxomil/chlorthalidone (AZL‐M/CLD) vs fixed‐dose combination olmesartan medoxomil/hydrochlorothiazide (OLM/HCTZ) in patients with essential hypertension (stage 2; clinic systolic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Hypertens (Greenwich)
Autori principali: Neutel, Joel M., Cushman, William C., Lloyd, Eric, Barger, Bruce, Handley, Alison
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2017
Soggetti:
Hypertension Therapy
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8031288/
https://ncbi.nlm.nih.gov/pubmed/28681550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi